Overview

Dynamic Lycra Orthosis as an Adjunct to Botulinum Toxin-A Injection for Post-stroke Spasticity

Status:
Completed
Trial end date:
2019-02-11
Target enrollment:
0
Participant gender:
Female
Summary
Upper extremity splints are one of the nonpharmacologic treatments used to treat hypertonicity after stroke. The purpose of splinting is to support, to position, to immobilize, to prevent contracture and deformities, to reduce spasticity and to enhance function. Dynamic lycra splints have been found to improve spasticity, posture, and fluency of upper extremity movements in computerized analysis systems due to the effects of neutral warmth, circumferential pressure and by creating a low intensity prolonged stretch on hypertonic muscles , all of which contribute to increased sensory awareness of the involved limb. These splints are frequently used in the field of neurological rehabilitation, but there is not enough scientific evidence about their efficacy. It was demonstrated that lycra sleeves have positive effects on upper extremity function of children with cerebral palsy. Lycra sleeves for upper extremity function after stroke is a relatively new field of research. The aim of this study is to investigate effects of dynamic lycra orthosis as an adjunct to botulinum toxin-a injection of the upper limb in adults following stroke.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Marmara University
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
onabotulinumtoxinA
Criteria
Inclusion Criteria:

1. Adult stroke (18-80 years)

2. Patients with stroke who can sit without support

3. Patients with stroke who have spasticity which limit upper limb function

Exclusion Criteria:

1. Brunnstrom motor recovery stage 1 and 6

2. Comorbidities such as hemiplegic shoulder pain, complex regional pain syndrome,
central post-stroke pain, brachial plexus injury etc.

3. Upper limb spasticity with MAS level 4 or presence of contracture in upper extremity.

4. Contraindications for lycra sleeve ( circulatory disorder etc.)

5. Contraindications for botulinum toxin (infection at the injection site,
hypersensitivity to toxin etc.)

6. Severe aphasia or cognitive dysfunction that limit participation in rehabilitation (7)
Receiving botulinum toxin injection within the last 6 months